Jeffrey L. Port
Founder at View Point Medical, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Peter Klemm | M | - |
View Point Medical, Inc.
 View Point Medical, Inc. Pharmaceuticals: MajorHealth Technology View Point Medical, Inc. engages in the provision of medical device and technology focuses on surgical outcomes using novel tissue markers that enable lesion localization in cancer care. It offers SignalMark platform. The company was founded by William Blair and Jeffrey Port and is headquartered in Carlsbad, CA. | - |
| William Blair | M | - |
View Point Medical, Inc.
View Point Medical, Inc. Pharmaceuticals: MajorHealth Technology View Point Medical, Inc. engages in the provision of medical device and technology focuses on surgical outcomes using novel tissue markers that enable lesion localization in cancer care. It offers SignalMark platform. The company was founded by William Blair and Jeffrey Port and is headquartered in Carlsbad, CA. | - |
| Paul W. Finnegan | M | 63 |
Angiocrine Bioscience, Inc.
 Angiocrine Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Angiocrine Bioscience, Inc. is a clinical-stage biotechnology company based on its novel and proprietary e-cel® platform. The company is based in San Diego, CA. The company is developing multiple e-cel therapies designed to repair damaged tissue from age-related degenerative disease of the musculoskeletal system, immune diseases that attack vessels and tissues, and ischemic diseases involving soft tissue, central nervous system, and the heart. The CEO of the company is Paul W. Finnegan. | - |
| Jeff Jonas | M | 71 |
Angiocrine Bioscience, Inc.
Angiocrine Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Angiocrine Bioscience, Inc. is a clinical-stage biotechnology company based on its novel and proprietary e-cel® platform. The company is based in San Diego, CA. The company is developing multiple e-cel therapies designed to repair damaged tissue from age-related degenerative disease of the musculoskeletal system, immune diseases that attack vessels and tissues, and ischemic diseases involving soft tissue, central nervous system, and the heart. The CEO of the company is Paul W. Finnegan. | - |
| Gary Pace | M | 76 |
View Point Medical, Inc.
View Point Medical, Inc. Pharmaceuticals: MajorHealth Technology View Point Medical, Inc. engages in the provision of medical device and technology focuses on surgical outcomes using novel tissue markers that enable lesion localization in cancer care. It offers SignalMark platform. The company was founded by William Blair and Jeffrey Port and is headquartered in Carlsbad, CA. | - |
| Josh Baltzell | M | 55 |
View Point Medical, Inc.
View Point Medical, Inc. Pharmaceuticals: MajorHealth Technology View Point Medical, Inc. engages in the provision of medical device and technology focuses on surgical outcomes using novel tissue markers that enable lesion localization in cancer care. It offers SignalMark platform. The company was founded by William Blair and Jeffrey Port and is headquartered in Carlsbad, CA. | - |
| David Parkinson | M | 73 |
Angiocrine Bioscience, Inc.
Angiocrine Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Angiocrine Bioscience, Inc. is a clinical-stage biotechnology company based on its novel and proprietary e-cel® platform. The company is based in San Diego, CA. The company is developing multiple e-cel therapies designed to repair damaged tissue from age-related degenerative disease of the musculoskeletal system, immune diseases that attack vessels and tissues, and ischemic diseases involving soft tissue, central nervous system, and the heart. The CEO of the company is Paul W. Finnegan. | - |
| John Merritt | M | - |
View Point Medical, Inc.
View Point Medical, Inc. Pharmaceuticals: MajorHealth Technology View Point Medical, Inc. engages in the provision of medical device and technology focuses on surgical outcomes using novel tissue markers that enable lesion localization in cancer care. It offers SignalMark platform. The company was founded by William Blair and Jeffrey Port and is headquartered in Carlsbad, CA. | - |
| John R. Jaskowiak | M | - |
Angiocrine Bioscience, Inc.
Angiocrine Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Angiocrine Bioscience, Inc. is a clinical-stage biotechnology company based on its novel and proprietary e-cel® platform. The company is based in San Diego, CA. The company is developing multiple e-cel therapies designed to repair damaged tissue from age-related degenerative disease of the musculoskeletal system, immune diseases that attack vessels and tissues, and ischemic diseases involving soft tissue, central nervous system, and the heart. The CEO of the company is Paul W. Finnegan. | - |
| Marc Cohen | M | - |
Angiocrine Bioscience, Inc.
Angiocrine Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Angiocrine Bioscience, Inc. is a clinical-stage biotechnology company based on its novel and proprietary e-cel® platform. The company is based in San Diego, CA. The company is developing multiple e-cel therapies designed to repair damaged tissue from age-related degenerative disease of the musculoskeletal system, immune diseases that attack vessels and tissues, and ischemic diseases involving soft tissue, central nervous system, and the heart. The CEO of the company is Paul W. Finnegan. | - |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 10 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jeffrey L. Port
- Personal Network
